Safety and Immunogenicity of CodaVax-RSV in Seropositive and Seronegative Children

Clinical trial NCT04919109 · TERMINATED

Trial details

NCT number: NCT04919109
Sponsor: Codagenix, Inc
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Respiratory Syncytial Virus Infections

Start date: 2023-03-28
Primary completion: 2025-06-26
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.